Report by the
Director-General
1.
The Executive Board, at its 144th session in January 2019, noted an earlier
version of this report.1 The draft road map has been revised and a new Appendix
2 has been added to indicate the linkage between the Thirteenth General
Programme of Work, 2019-2023 and the activities, actions, deliverables and
milestones set out in the road map. The milestones have been updated to reflect
the global goods planning process, and information has been added on the
Organization’s mandate with regard to the actions required by the road map and
on the distribution of road map activities across the programme budget. The
revised draft also reflects issues raised by the Executive Board relating to
providing health products for primary health care, monitoring access,
optimizing the use of biosimilars, addressing the challenges faced by small
island States, and supporting countries transitioning from donor funding.2
2.
In May 2018, the Seventy-first World Health Assembly considered a report by the
Director-General on addressing the global shortage of, and access to, medicines
and vaccines.3 The report focused on a list of priority options for actions to
be considered by Member States and presented a comprehensive report by the
Director-General on access to essential medicines and vaccines.
3.
Having considered the report, the Health Assembly adopted decision WHA71(8), in
which it decided to request the Director-General to elaborate a road map
report, in consultation with Member States, outlining the programming of WHO’s
work on access to medicines and vaccines for the period 2019–2023, including
activities, actions and deliverables. The Health Assembly also requested the
Director-General to submit the road map report to the Seventy-second World
Health Assembly, through the Executive Board at its 144th session.
4.
In July 2018, the Secretariat initiated a process to consult Member States and
an online consultation with Member States on the zero draft road map was
conducted in the period July–September 2018, during which 62 countries provided
feedback. In addition, a consultation with Member States on the zero draft was
conducted on 10 and 11 September 2018 in Geneva, preceded by an informal
discussion with representatives of the United Nations and other international
organizations and non-State actors in official relations with WHO. The draft
report was updated based on the feedback obtained by these consultation
processes, including broadening of the scope to include medicines, vaccines and
health products.
5.
The revised draft road map for access to medicines, vaccines and other health
products, 2019–2023, based on existing WHO mandates in key Health Assembly
resolutions of the last 10 years related to access to safe, effective and
quality medicines, vaccines and health products, and also reflecting the
Thirteenth General Programme of Work, 2019–2023, is contained in the Annex.1
6.
The Health Assembly is invited to note the draft road map for access to
medicines, vaccines and other health products, 2019–2023, as contained in the
Annex.
1 See document EB144/17 and
summary record of the Executive Board at its 144th session, ninth and tenth
meeting.
2 See the summary records
of the Executive Board at its 144th session, tenth meeting.
3 Document A71/12.
Anexo:
0 comentários:
Postar um comentário